NASDAQ: NPCE - NeuroPace, Inc.

Yield per half year: +47.58%
Dividend yield: 0.00%
Sector: Healthcare

NeuroPace, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 61.47 -100% -6.32 -100%
P/S 3.91 33.58 -88.35%
P/BV 12.39 4.79 158.57%
P/FCF 0 60.06 -100%
Ev/Ebitda -12.13 -17.26 -29.7%
Ev/S 4.74 22.49 -78.91%
Ev/FCF -15.61 67.63 -123.08%
E/P 0 0.0168 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-39.08 4.5 -969.22% -52.53 -25.6%
ROE -159.56 9.39 -1799.04%
ROA -30.61 0.1519 -20250.63%
ROIC 0 7.63 -100%
ROS -50.38 -25.64 96.48%
ROCE -131.57 15.19 -966.37%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-2.29 -3.68 -37.72% -2.28 +0.3329%
Nеt Debt/Ebitda -2.13 -4.07 -47.74%
Debt/Ratio 0.5442 0.199 173.44%
Debt/Equity 0 1.67 -100%
Debt/Net Income -1.78 10.34 -117.19%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5399 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2331 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.4916 -100%
Average percentage for payments 0 43.32 -100%
Difference from average difference in sector -0.5399

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
76.81 76.2 0.8005%
Growth impulse Ebitda in 5 years 13.6 44.75 -69.61%
Growth impulse Net Income in 5 years -19.03 -15.36 23.89%
Growth impulse FCF in 5 years -22.06 -9.39 134.93%
Growth impulse EPS in 5 years -65.26 -84.03 -22.34%
IP Score
3.09/10

Similar companies

Incyte

Amarin

ImmunoGen

DENTSPLY SIRONA

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription